Back
Inozyme Pharma Vs. Pro-Dex Industry Stock Comparison
Sell
23
INZY
Inozyme Pharma
Last Price:
$2.80
Seasonality Move:
117.98%
Buy
68
PDEX
Pro-Dex
Last Price:
$51.49
Seasonality Move:
10.27%
Sell
23
Inozyme Pharma (INZY)
is a Sell
Is Inozyme Pharma a Buy, Sell or Hold?
-
The current Inozyme Pharma [INZY] share price is $2.82. The Score for INZY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
INZY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INZY Stock Price Chart
What is Inozyme Pharma's stock price today?
-
The Inozyme Pharma share price today is $2.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INZY is experiencing slight selling pressure.
INZY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 43.98 | Sell |
Chaikin Money Flow: | -280469 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.71 - 3.01) | Sell |
Bollinger Bands (100): | (3.12 - 5.4) | Sell |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 55.69 | Buy |
Chaikin Money Flow: | -20256 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.32 - 52.22) | Buy |
Bollinger Bands (100): | (24.46 - 47.06) | Buy |
INZY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.9 | Sell |
20-day SMA: | 2.92 | Sell |
50-day SMA: | 3.25 | Sell |
200-day SMA: | 4.63 | Sell |
8-day EMA: | 2.89 | Sell |
20-day EMA: | 2.93 | Sell |
50-day EMA: | 3.32 | Sell |
200-day EMA: | 4.3 | Sell |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.35 | Buy |
20-day SMA: | 48.53 | Buy |
50-day SMA: | 45.81 | Buy |
200-day SMA: | 27.28 | Buy |
8-day EMA: | 50.13 | Buy |
20-day EMA: | 48.86 | Buy |
50-day EMA: | 44.85 | Buy |
200-day EMA: | 31.31 | Buy |
Inozyme Pharma Earnings Growth & INZY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.20 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $0.06 per share.
Inozyme Pharma Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |